Ozempic's popularity leads to shortages for people with Type 2 diabetes

United States News News

Ozempic's popularity leads to shortages for people with Type 2 diabetes
United States Latest News,United States Headlines
  • 📰 NPR
  • ⏱ Reading Time:
  • 72 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 32%
  • Publisher: 63%

Drugs like Ozempic, Wegovy and Mounjaro are in such high demand that many patients with Type 2 diabetes can't get them when they need them.

A T-shirt from fashion brand Namilia shown during Berlin Fashion on July 3, 2024 sparked an outcry on the brand's Instagram, with readers noting that Ozempic is in short supply for people with a medical need for it.Jim Cox had heard of people with Type 2 diabetes who were unable to get Ozempic because the drug was being used off-label for weight loss. He just didn’t think the shortage would affect him.

Cox says the pharmacist suggested calling a few times a week to see if the drug was back in stock. He wound up needing to ration his Trulicity to make it last longer.He’s right. Missing doses can lead to uncontrolled blood sugar for people with Type 2 diabetes, and that can snowball into kidney and eye complications, for example. Trulicity and similar diabetes drugs like Ozempic and Mounjaro, have all been in short supply over the last 18 months.

. “It's sad that we received that many.” The tool, which is available even to those who aren’t Ro.co customers, also tells people when it finds a supply of their GLP-1 drug within 100 miles of where they live.Boston University health economist Rena Conti. Still, Ozempic’s immense popularity, fueled by Hollywood, social media influencers and ubiquitous ads on social media, means there are also people taking these drugs who want to lose a few pounds for cosmetic reasons.

“Although Wegovy and Ozempic both contain semaglutide, they are different products with different indications, dosages, prescribing information, titration schedules, and delivery forms,” Eric Althoff, speaking on behalf of Novo Nordisk, wrote in an email to NPR. “The products are not interchangeable and should not be used outside of their FDA-approved indications.”Still, it turns out that conserving medicines for the people they were approved to treat is challenging.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NPR /  🏆 96. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ozempic, Wegovy scams skyrocket as demand surges for expensive weight loss drugsOzempic, Wegovy scams skyrocket as demand surges for expensive weight loss drugsScams targeting weight loss-related drugs such as Ozempic and Wegovy have proliferated, putting consumers who are seeking to purchase the medication at serious risk.
Read more »

Weight Loss Drugs Like Wegovy and Ozempic May Influence How Food Tastes, Study FindsWeight Loss Drugs Like Wegovy and Ozempic May Influence How Food Tastes, Study FindsIn 'An Oprah Special: Shame, Blame and the Weight Loss Revolution,' Oprah talks obesity and weight loss drugs.
Read more »

GLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding ConditionGLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding ConditionTrendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns.
Read more »

Wegovy and Ozempic Could Spike Risk of Blindness-Causing Condition, Study SaysWegovy and Ozempic Could Spike Risk of Blindness-Causing Condition, Study SaysDigital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Read more »

Zepbound outperforms Ozempic and Wegovy in head-to-head weight loss studyZepbound outperforms Ozempic and Wegovy in head-to-head weight loss studyThe World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News' Anne Thompson reports.
Read more »

Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, WegovyNovo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, WegovyNovo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
Read more »



Render Time: 2025-02-22 02:28:59